Education

  • Columbia University, BA, 05/2005, Chemistry
  • Massachusetts Institute of Technology, PhD, 06/2010, Chemistry
  • Stanford University School of Medicine, MD, 06/2014, Medicine
  • University of California, San Francisco, Residency, 06/2018, Anatomic and Clinical Pathology
  • University of California, San Francisco, Fellowship, 06/2019, Cytopathology
  • University of California, San Francisco, Fellowship, 11/2019, Surgical Pathology

Selected Publications

  1. Greenland NY, Cowan JE, Ding CC, Sirohi D, Cooperberg MR, Carroll PR, Simko JP, Stohr BA, Zhang L, Chan E Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence.  View on PubMed
  2. McKenney JK, Brooks JD, Nguyen JK, Ding CKC, Newcomb LF, Myles JL, Alaghehbandan R, Przybycin CG, Chan E, Simko JP, Greenland NY, Schwen Z, Weight CJ, Cooperberg MR, Carroll PR In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'.  View on PubMed
  3. Khorsandi N, Porten S, VandenBussche CJ, Greenland N, Vohra P Bridging Perspectives: Integrating urologist and cytopathologist insights of urine cytology.  View on PubMed
  4. Sirohi D, Cornelia Ding CK, Stohr BA, Balassanian R, Vohra P, Aggarwal R, Chan E, Greenland NY The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies.  View on PubMed
  5. Wadhwa A, Johnson H, Bobba KN, Bidkar AP, Mayne E, Rampersaud S, Mandal K, Barpanda A, Prudhvi S, Kang AS, Greenland N, Balitzer D, Peter R, Raveendran A, Naik S, Basak M, Kasap C, Huebner J, Alvarez ML, Lee S, Steri V, Adams JJ, Sidhu SS, Wilson DM, Seo Y, VanBrocklin HF, Logan AC, Wiita AP, Flavell RR Effective imaging and treatment of Acute Myeloid Leukemia with radiotheranostics targeting the activated conformation of integrin-ßeta2.  View on PubMed
  6. Ding CC, Xiao H, Nguyen JK, Przybycin CG, Alaghehbandan R, Myles JL, Greenland NY, Simko JP, Sirohi D, Stohr BA, McKenney JK Classification of prostatic adenocarcinoma as favourable/unfavourable histology has high interobserver agreement in prostate needle core biopsies.  View on PubMed
  7. Downes MR, Lopez-Beltran A, Contieri R, Hansel DE, Paner GP, Shen S, van Rhijn BWG, Al-Ahmadie H, Amin MB, Brunelli M, Comperat E, Cookson MS, Faltas BM, Guo CC, Hartmann A, Kamat AM, Mertens LS, Ross JS, van der Kwast TH, Warrick J, Kristiansen G, Cheng L, Raspollini MR, Members of ISUP GU Cancer Precursor Consensus Panel. International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder. Am J Surg Pathol. 2025 Jul 01.  View on PubMed
  8. Iczkowski KA, De Marzo AM, Agarwal N, Berman DM, Cimadamore A, Fine SW, Greenland N, Khani F, Loda M, Lotan TL, Varma M, Chinnaiyan A, Giannarini G, Huang J, Montironi R, Netto GJ, Osunkoya AO, Ratliff T, Kristiansen G, Cheng L, van Leenders GJLH, Members of the ISUP GU Cancer Precursor Consensus Panel. International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1: The Prostate. Am J Surg Pathol. 2025 Jun 23.  View on PubMed
  9. Bobba KN, Wadhwa A, Bidkar AP, Raveendran A, Garcia L, Greenland N, Wilson DM, Seo Y, VanBrocklin HF, Flavell RR. Evaluation of 134Ce/134La-PSMA-617 for PET Imaging and Auger Electron Therapy of Prostate Cancer. J Nucl Med. 2025 Jun 12.  View on PubMed
  10. Shee K, Cowan JE, Ding CC, Wang L, Pace W, Greenland N, Simko JP, Washington SL, Shinohara K, Nguyen HG, Cooperberg MR, Carroll PR. Gleason Grade Group 3 Represents a Spectrum of Disease: Results from a Large Institutional Cohort. Eur Urol Focus. 2025 May 14.  View on PubMed
  11. Bidkar AP, Peter R, Wadhwa A, Bobba KN, Bidlingmaier S, Meher N, Chou J, Greenland N, Dasari C, Naik S, Raveendran A, Basak M, Camara Serrano JA, Steri V, Kogan S, Oskowitz A, He J, Wilson DM, Aggarwal R, Sriram R, VanBrocklin HF, Seo Y, Liu B, Flavell RR. Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy. Clin Cancer Res. 2025 Feb 13.  View on PubMed
  12. Ding CC, Greenland NY, Sirohi D, Lotan TL. Molecular Landscape of Aggressive Histologic Subtypes of Localized Prostate Cancer. Surg Pathol Clin. 2025 Mar; 18(1):1-12.  View on PubMed
  13. Bernhardt M, Weinhold L, Bremmer F, Chan E, Cheng L, Collins K, Downes M, Greenland N, Hommerding O, Iczkowski KA, Jufe L, Kreft T, van Leenders G, Oxley J, Perry-Keene J, Reis H, Schmid M, Tsuzuki T, Wobker S, Wiliamson SR, Kweldam C, Kristiansen G. Unexpectedly high variability in determining tumour extent in prostatic biopsies: implications for active surveillance. Histopathology. 2025 Mar; 86(4):627-639.  View on PubMed
  14. Tsao T, Qiu L, Bharti R, Shemesh A, Hernandez AM, Cleary SJ, Greenland NY, Santos J, Shi R, Bai L, Richardson J, Dilley K, Will M, Tomasevic N, Sputova T, Salles A, Kang J, Zhang D, Hays SR, Kukreja J, Singer JP, Lanier LL, Looney MR, Greenland JR, Calabrese DR. CD94+ natural killer cells potentiate pulmonary ischaemia-reperfusion injury. Eur Respir J. 2024 Sep; 64(3).  View on PubMed
  15. Balitzer DJ, Greenland NY. The utility of next-generation sequencing in challenging liver FNA biopsies. Cancer Cytopathol. 2024 Nov; 132(11):714-722.  View on PubMed
  16. Yoon H, Chen CV, Krishnan V, Grochowski J, Iezza G, Vohra P, Balassanian R, Greenland NY. Utility and performance of cell blocks in cerebrospinal fluid cytology: Experience at two teaching hospitals. Cancer Cytopathol. 2024 Oct; 132(10):621-628.  View on PubMed
  17. Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR. Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer. Adv Healthc Mater. 2024 Jul; 13(19):e2304618.  View on PubMed
  18. Greenland NY, Cooperberg MR, Carroll PR, Cowan JE, Simko JP, Stohr BA, Chan E. Morphologic patterns observed in prostate biopsy cases with discrepant grade group and molecular risk classification. Prostate. 2024 Aug; 84(11):1076-1085.  View on PubMed
  19. Chen CV, Krishnan V, Greenland NY. A case series of thyroid fine needle aspiration biopsies diagnosed as follicular neoplasm with oncocytic features. Diagn Cytopathol. 2024 Oct; 52(10):553-557.  View on PubMed
  20. Bobba KN, Bidkar AP, Wadhwa A, Meher N, Drona S, Sorlin AM, Bidlingmaier S, Zhang L, Wilson DM, Chan E, Greenland NY, Aggarwal R, VanBrocklin HF, He J, Chou J, Seo Y, Liu B, Flavell RR. Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Theranostics. 2024; 14(4):1344-1360.  View on PubMed

Go to UCSF Profiles, powered by CTSI